NeemaNavaiMD

Urology • Houston, TX

Surgical Oncology

Assistant Professor, Urology The University of Texas MD Anderson Cancer Center

Join to view full profile

Dr. Navai is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Navai's full profile

Already have an account?

Office
1515 Holcombe Blvd
unit 1373
Houston, TX 77030
Phone+1 713-792-3250

Education & Training

McGaw Medical Center of Northwestern UniversityResidency, Urology, 2006 - 2010
McGaw Medical Center of Northwestern UniversityResidency, Surgery, 2004 - 2006
Northwestern University The Feinberg School of MedicineClass of 2004

Certifications & Licensure

FL State Medical License 2021 - Present
AZ State Medical License 2022 - 2026
GA State Medical License 2022 - 2026
TN State Medical License 2022 - 2026
TX State Medical License 2010 - 2026
AL State Medical License 2022 - 2025
LA State Medical License 2022 - 2025
MS State Medical License 2022 - 2025
OK State Medical License 2020 - 2025
WA State Medical License 2022 - 2025
NC State Medical License 2021 - 2022
IL State Medical License 2004 - 2011
American Board of Urology Urology
Join now to see all

Clinical Trials

Improving Clinical Staging for Muscle Invasive Bladder Cancer Through Molecular Profiling and Improved Imaging Start of enrollment: 2014 Jun 25
Completed
Pembrolizumab in Treating Patients With Bladder Cancer Undergoing Radical Cystectomy Start of enrollment: 2018 Jan 11
Completed
Phase 2
Evaluating Sexual Function in Women Undergoing a Radical Cystectomy for Bladder Cancer Start of enrollment: 2019 Sep 03
Active, not recruiting
Roles: Principal Investigator, Contact
A Window of Opportunity Phase I Study of UGN-201 in Patients With Bladder Cancer Undergoing Radical Cystectomy Protocol #: 2021-0630 Start of enrollment: 2022 Jan 24
Suspended
Phase 1
Roles: Contact, Principal Investigator
Measuring Surgical Recovery After Radical Cystectomy Start of enrollment: 2015 Apr 30
Recruiting
Roles: Principal Investigator, Contact
Join now to see all

Publications & Presentations

PubMed

Bladder-preserving radiation therapy for patients with locally advanced and node-positive bladder cancer.
Patrick Carriere, Omar Alhalabi, Jianjun Gao, Osama Mohamad, Matthew T Campbell
Clinical and Translational Radiation Oncology. 2024-11-01
2 citations
Challenging the Paradigm of "BCG-unresponsive" Bladder Cancer: Does Additional Bacillus Calmette-Guérin Have an Effect?
Amanda A Myers, Wei Shen Tan, Valentina Grajales, Hyunsoo Hwang, Kelly K Bree
European Urology. 2024-10-01
A Pilot Study of the CD38 Antagonist Daratumumab in Patients with Metastatic Renal Cell Carcinoma or Muscle-Invasive Bladder Cancer.
Matthew T Campbell, Amishi Y Shah, Pavlos Msaouel, Nizar M Tannir, Arlene O Siefker-Radtke
Cancer Research Communications. 2024-09-01

Press Mentions

MDACC 2018: Optimizing the Management of cT2N0 DiseaseNovember 11th, 2018
MDACC 2018: Update in Robotic vs Open Radical Cystectomy – Where Do We Stand in 2018?November 11th, 2018
Cancer Care’s Virtual RevolutionMarch 30th, 2021
Join now to see all